JPRN-jRCT2080222863已完成3 期
KRP-AM1977X PhaseIII Clinical Study
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
Once daily administration of KRP-AM1977X was highly effective for otolaryngological infections.In the safety assessment, no major problem was observed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Otorhinolaryngological infection with clear infection symptoms
排除标准
- •Patient with serious functional disorder that would unsuitable for the study
- •Patient showing the tendency to improve symptoms by other agents
研究者
相似试验
已完成
3 期
KRP-AM1977X Phase III Open-label Study (Respiratory Tract Infection)Secondary infection of chronic respiratory disease and acute bronchitisJPRN-jRCT2080222861Kyorin Pharmaceutical Co.,LTD53
已完成
3 期
A Phase III , open-label study of KRP-AM1977Y in respiratory tract infectioJPRN-jRCT2080223247Kyorin Pharmaceutical Co.,LTD78
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacological study)JPRN-jRCT2080222747Kyorin Pharmaceutical Co.,LTD15
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacological study)Japanese healthy adult male subjectsJPRN-jRCT2080225163Kyorin Pharmaceutical Co., Ltd.54
已完成
3 期
KRP-AM1977X Phase III Comparative Study (sinusitis)Sinusitis (severity of infection: moderate to severe)JPRN-jRCT2080222862Kyorin Pharmaceutical Co.,LTD279